Evidence map›Paper›PMID 32936831›Full record

ArticlePLoS pathogens2020

Evidence that immunization with TP0751, a bipartite Treponema pallidum lipoprotein with an intrinsically disordered region and lipocalin fold, fails to protect in the rabbit model of experimental syphilis.

Amit Luthra, Jairo M Montezuma-Rusca, Carson J La Vake, Morgan LeDoyt, Kristina N Delgado, Timothy C Davenport, Mary Fiel-Gan, Melissa J Caimano, Justin D Radolf, Kelly L Hawley

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 27 citations in OpenAlex.

  1. High Prevalence of Haemophilus ducreyi Among Patients With Suspected Primary syphilis in Malawi, 2019-2022.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  2. Clinical characteristics ofResearch square · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Participants inFrontiers in immunology · 2025
    Review
  7. Article
  8. Development and utilization ofbioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Immunodominant extracellular loops ofbioRxiv : the preprint server for biology · 2024
    Article
  11. Comprehensive Overview ofCurrent protein & peptide science · 2024
    Review
  12. Review
  13. Review
  14. Immunization with Tp0954, an adhesin ofFrontiers in immunology · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Leptolysin, aFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Amit LuthraDepartment of Medicine, UConn Health, Farmington, United States of America.
Jairo M Montezuma-RuscaDepartment of Medicine, UConn Health, Farmington, United States of America.ORCID 0000-0002-8391-1242
Carson J La VakeDepartment of Pediatrics, UConn Health, Farmington, United States of America.ORCID 0000-0001-8894-7298
Morgan LeDoytDepartment of Medicine, UConn Health, Farmington, United States of America.ORCID 0000-0001-7880-6854
Kristina N DelgadoDepartment of Medicine, UConn Health, Farmington, United States of America.ORCID 0000-0003-3041-5170
Timothy C DavenportDepartment of Medicine, UConn Health, Farmington, United States of America.
Mary Fiel-GanDepartment of Pathology, Hartford Hospital, Hartford, United States of America.
Melissa J CaimanoDepartment of Medicine, UConn Health, Farmington, United States of America.ORCID 0000-0003-1170-4102
Justin D RadolfDepartment of Medicine, UConn Health, Farmington, United States of America.
Kelly L HawleyDepartment of Pediatrics, UConn Health, Farmington, United States of America.ORCID 0000-0001-8587-1662
UConn Health · USConnecticut Children's Medical Center · USHartford Hospital · US

Funding

Prevalence of syphilis and other sexually transmitted infections in men and transgender women who have sex with men in Cali, ColombiaU19AI144177 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MOODY, MICHAEL ANTHONY, RADOLF, JUSTIN D · 2019 to 2023
$11.2M
Treponema pallidum Outer Membrane Proteins and Transition Metal AcquisitionR01AI026756 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI RADOLF, JUSTIN D · 1992 to 2017
$5.1M
NIAID NIH HHS R01 AI026756NIAID NIH HHS U19 AI144177
6 · The paper itself

Abstract

Deconvolution of syphilis pathogenesis and selection of candidate syphilis vaccinogens requires detailed knowledge of the molecular architecture of the Treponema pallidum outer membrane (OM). The T. pallidum OM contains a low density of integral OM proteins, while the spirochete's many lipoprotein immunogens are periplasmic. TP0751, a lipoprotein with a lipocalin fold, is reportedly a surface-exposed protease/adhesin and protective antigen. The rapid expansion of calycin/lipocalin structures in the RCSB PDB database prompted a comprehensive reassessment of TP0751. Small angle X-ray scattering analysis of full-length protein revealed a bipartite topology consisting of an N-terminal, intrinsically disordered region (IDR) and the previously characterized C-terminal lipocalin domain. A DALI server query using the lipocalin domain yielded 97 hits, 52 belonging to the calycin superfamily, including 15 bacterial lipocalins, but no Gram-negative surface proteins. Surprisingly, Tpp17 (TP0435) was identified as a structural ortholog of TP0751. In silico docking predicted that TP0751 can bind diverse ligands along the rim of its eight-stranded β-barrel; high affinity binding of one predicted ligand, heme, to the lipocalin domain was demonstrated. qRT-PCR and immunoblotting revealed very low expression of TP0751 compared to other T. pallidum lipoproteins. Immunoblot analysis of immune rabbit serum failed to detect TP0751 antibodies, while only one of five patients with secondary syphilis mounted a discernible TP0751-specific antibody response. In opsonophagocytosis assays, neither TP0751 nor Tpp17 antibodies promoted uptake of T. pallidum by rabbit peritoneal macrophages. Rabbits immunized with intact, full-length TP0751 showed no protection against local or disseminated infection following intradermal challenge with T. pallidum. Our data argue that, like other lipoprotein lipocalins in dual-membrane bacteria, TP0751 is periplasmic and binds small molecules, and we propose that its IDR facilitates ligand binding by and offloading from the lipocalin domain. The inability of TP0751 to elicit opsonic or protective antibodies is consistent with a subsurface location.

Indexed as

ImmunizationAnimalsBacterial ProteinsBacterial VaccinesHumansLipoproteinsProtein DomainsProtein FoldingRabbitsSyphilisTreponema pallidumBacterial ProteinsBacterial VaccinesLipoproteins

Identifiers

PMID32936831
PMCPMC7521688
OpenAlexW3087304529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.